On June 28th, 2022, the Cluster Saúde de Galicia, CSG, hosted the fifth capitalization meeting for the neuroATLANTIC project in collaboration with Denis Vivien, representing the French consortium member Inserm. Besides the capitalization of the research results of neuroATLANTIC, this meeting focused on sketching a better overview of the French neurology field.
After the CSG presented the project and results to the participants, presentations were provided by the French stakeholders. As part of Inserm, Blood and Brain at Caen-Normandy (BB@C) was represented by Denis Vivien. BB@C is a French institute that performs research in blood and brain related diseases.
Moreover, two French start-ups, Op2Lysis – a company working on creating a solution to improve the management and treatment, among which is their NANOp2Lysis solution – and Samdoc – a company that developed NEWA and SMTA, two solutions that are focused on the improvement of clinical observation in and out of the hospital – provided an overview of their work.
Although this hybrid meeting mainly focused on the French neurology ecosystem, British company Brainomix shared its innovative e-Stroke development. E-Stroke is a mobile application developed to combine multiple, already existing imaging modalities that automatically process CT images to provide prompt, clinically useful information in an acute stroke setting. As a result of this meeting, new connections were made, and possible collaboration opportunities were identified. France has acknowledged the importance of addressing age-related neurological disorders due to the growing elderly population. Thus, sharing of knowledge, innovation, and the establishment of new connections will contribute to tackling neurological diseases and accelerating the uptake of innovative solutions. The full meeting report including all details can be downloaded here.